# SAXENDA
> **NDA206321** · New Drug Application · Sponsor: NOVO · Approved 2014-12-23
## Drug
- **FDA Application Number:** NDA206321
- **Application type:** New Drug Application
- **Brand name:** SAXENDA
- **Generic name:** LIRAGLUTIDE
- **Active ingredients:** LIRAGLUTIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** NOVO
- **Manufacturer:** Novo Nordisk
- **First approval:** 2014-12-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206321)
---
*AI Analytics · CC0 1.0*